Risk factors associated with methamphetamine use and heart failure among Native Hawaiians and other Pacific Island peoples

Vascular Health and Risk Management

Volumn 5, Issue , 2009, Pages 45-52

  Mau, Marjorie K ^a   Asao, Karynna ^b   Efird, Jimmy ^a   Saito, Erin ^d   Ratner, Robert ^c   Hafi, Muhannad ^c   Seto, Todd ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b Claremont College   (United States)

^c MedStar Research Institute   (United States)

^d NONE

Author keywords

Ethnic minority; Heart failure; Methamphetamine use; Native Hawaiian and other Pacific Islander

Indexed keywords

METHAMPHETAMINE; CENTRAL STIMULANT AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; PACIFIC ISLANDS; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; ABORIGINE; AGE; CROSS-SECTIONAL STUDY; DIVORCE; DRUG ABUSE; ETHNOLOGY; FAMILY SIZE; HEALTH DISPARITY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS;

ADULT; AGE FACTORS; AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-SECTIONAL STUDIES; DIVORCE; FEMALE; HAWAII; HEALTH STATUS DISPARITIES; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; METHAMPHETAMINE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SINGLE PERSON; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 67449107304     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. NIDA Research Report. Methamphetamine abuse and addiction: NIH Publication No 06-4210: NIDA Research Report; 2006.
2. Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings Rockville, MD: Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194; 2006.
3. Alcohol and Drug Abuse Division, Hawaii Department of Health. Substance abuse in Hawaii: adult population household telephone survey. Kapolei, HI; 1998.
4. Alcohol and Drug Abuse Division, Hawaii Department of Health. Substance abuse and treatment needs: survey estimates for Hawai'i. Kapolei, HI; 1998.
5. Alcohol and Drug Abuse Division, Hawaii Department of Health. Ka leo o na keiki: the 2003 Hawaii student alcohol, tobacco, and other drug use study (1987-2003). Kapolei, HI; 2003.
6. Hong R, Matsuyama E, Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA. 1991;265(9):1152-4.
7. Inouye DS, Navin JJ, Hardman JM. Fatal postoperative arrhythmia in a man with a remote history of methamphetamine and cocaine use: a case report. Hawaii Med J. 2004;63(3):82-6.
8. Wijetunga M, Seto T, Lindsay J, Schatz I. Crystal methamphetamine- associated cardiomyopathy: tip of the iceberg? J Toxicol Clin Toxicol. 2003;41(7):981-6.
9. Yeo KK, Wijetunga M, Ito H, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med. 2007;120(2):165-71.
10. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: DAWN Series D-28, DHHS Publication No. (SMA) 06-4143 2006.
11. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: DAWN Series D-29, DHHS Publication No. (SMA) 07-4256;2007.
12. Jacobs LJ. Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol. 1989;12(12):725-7.
13. American Heart Association. Heart disease and stroke statistics - 2007 update. Dallas, Texas: American Heart Association; 2007.
14. Bosworth HB, Steinhauser KE, Orr M, Lindquist JH, Grambow SC, Oddone EZ. Congestive heart failure patients' perceptions of quality of life: the integration of physical and psychosocial factors. Aging Ment Health. 2004;8(1):83-91.
15. Jerant AF, von Friederichs-Fitzwater MM, Moore M. Patients' perceived barriers to active self-management of chronic conditions. Patient Educ Couns. 2005;57(3):300-7.
16. Yancy CW. The prevention of heart failure in minority communities and discrepancies in health care delivery systems. Med Clin North Am. 2004;88(5):1347-1368, xii-xiii.
17. Chen YT, Vaccarino V, Williams CS, Butler J, Berkman LF, Krumholz HM. Risk factors for heart failure in the elderly: a prospective community-based study. Am J Medicine. 1999;106(6):605-12.
18. He SY, Matoba R, Fujitani N, Sodesaki K, Onishi S. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol. 1996;17(2):155-62.
19. Varner KJ, Ogden BA, Delcarpio J, Meleg-Smith S. Cardiovascular responses elicited by the "binge" administration of methamphetamine. J Pharmacol Exp Ther. 2002;301(1):152-9.
20. Islam MN, Kuroki H, Hongcheng B, et al. Cardiac lesions and their reversibility after long term administration of methamphetamine. Forensic Sc Int. 1995;75(1):29-43.
21. Kaiho M, Ishiyama I. Morphological study of acute myocardial lesions experimentally induced by methamphetamine. Nihon Hoigaku Zasshi. 1989;43(6):460-8.
22. Kalant H, Kalant OJ. Death in amphetamine users: causes and rates. Can Med Assoc J. 1975;112(3):299-304.
23. Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci. 1999;44(2):359-68.
24. Logan BK, Fligner CL, Haddix T. Cause and manner of death in fatalities involving methamphetamine. J Forensic Sci. 1998;43(1):28-34.
25. Maeno Y, Iwasa M, Inoue H, Koyama H, Matoba R, Nagao M. Direct effects of methamphetamine on hypertrophy and microtubules in cultured adult rat ventricular myocytes. Forensic Sci Int. 2000;113(1-3):239-43.
26. Maruta T, Nihira M, Tomita Y. [Histopathological study on acute poisoning of methamphetamine, morphine or cocaine]. Nihon Arukoru Yakubutsu Igakkai Zasshi. 1997;32(2):122-38.
27. Robinson M, Turnipseed S, Glatter K. Methamphetamine-associated cardiomyopathy: a previously unrecognized cause of heart failure. American Heart Association Annual Scientific Sessions. New Orleans; 2004.
28. Smith HJ, Roche AH, Jausch MF, Herdson PB. Cardiomyopathy associated with amphetamine administration. Am Heart J. 1976;91(6):792-7.
29. Grandinetti A, Chang HK, Mau MK, et al. Prevalence of glucose intolerance among Native Hawaiians in two rural communities. Native Hawaiian Health Research (NHHR) Project. Diabetes Care. 1998;21(4):549-54.
30. Vasan RS, Wilson PW. Epidemiology and causes of heart failure. UpToDate Online 15.3. Accessed November 28, 2007. Available from www.uptodate.com.
31. Rumsfeld JS, Havranek E, Masoudi FA, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003;42(10):1811-7.
32. Deswal A, Petersen NJ, Urbauer DL, Wright SM, Beyth R. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J. 2006;152(2):348-54.
33. Miller LW. Heart Failure: Who We Treat Versus Who We Study. Cardiol Clin. 2008;26:113-25.
34. Rohrbaugh MJ, Shoham V, Coyne JC. Effect of marital quality on eight-year survival of patients with heart failure. Am J Cardiol. 2006;98(8):1069-72.
35. Rodriguez-Artalejo F, Guallar-Castillon P, Herrera MC, et al. Social network as a predictor of hospital readmission and mortality among older patients with heart failure. Journal of Cardiac Failure. Oct 2006;12(8):621-7.
36. Ni H, Nauman D, Burgess D, Wise K, Crispell K, Hershberger RE. Factors influencing knowledge of and adherence to self-care among patients with heart failure. Arch Int Med. 1999;159(14):1613-9.
37. Heidenreich PA, Spertus JA, Jones PG, et al. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006;47(4):752-6.
38. Gottlieb SS, Mann DL, Francis GS. Highlights of the 2006 scientific sessions of the Heart Failure Society of America: Seattle, Washington, September 10-13, 2006. J Am Coll Cardiol. 2007;49(5):608-15.
39. Rich MW, Nease RF. Cost-effectiveness analysis in clinical practice: the case of heart failure. Arch Int Med. 1999;159(15):1690-700.